AlleSense Raises $5M in Funding Round Led by Welcome Ventures

Deal Summary

Australian biotech spin‑out AlleSense announced a $5 million funding round to advance its NanoMslide cancer diagnostic technology. The round was led by existing investor Welcome Ventures, with contributions from Breakthrough Victoria, the AEA Innovate grant program and La Trobe University. The capital will support further development and commercialization of its pathology‑imaging platform.